Welcome!

News Feed Item

Web Tool Highlights Ongoing Impact of Tuberculosis in the United States

Aeras releases TB Crisis Tracker on World TB Day

ROCKVILLE, Md., March 24, 2014 /PRNewswire/ -- The tuberculosis epidemic continues to impact pockets of the U.S. population, according to a data visualization tool developed by the nonprofit biotech, Aeras.  Launched on World TB Day, Aeras's TB Crisis Tracker illustrates how the TB epidemic continues to impact the U.S.

"TB's impact in the U.S. is but a fraction of what it once was, but the Aeras TB Crisis Tracker starkly demonstrates that TB is not a disease of the past, or limited to the poorest countries in the world, but rather one that can strike anywhere, in any population, and at any time," said Kari Stoever, Vice President for External Affairs at Aeras. "This tool provides a powerful reminder that a reported case of TB represents more than just a number on a disease ledger. Each TB case represents a human being, with a name, a face, a story, and a community at risk for exposure."

Often thought to be a disease of the past, TB none-the-less remains a disease of the present, both around the world and in the United States. TB kills 1.3 million people each year, and drug-resistant strains of the disease are making it more difficult and costly to treat. The number of new TB cases occurring in the United States is at an all-time low, but with an increasing proportion of domestic cases occurring among foreign-born residents, the domestic burden of disease is becoming increasingly linked with the global TB epidemic. Until TB is eliminated globally, it will remain a public health threat in the U.S., particularly among at-risk groups, including international travelers, health care workers, first responders and those who work with prisoners and the homeless.

The Tracker highlights a sampling of recent U.S. TB cases occurring in schools, hospitals and other settings that have generated media attention over the past year.  Aeras's goal is to use this tool to raise awareness about the ongoing impact of TB and bring more transparency and attention to reports of TB outbreaks in the U.S. 

The most effective way to stop an epidemic like TB is to prevent its spread. As with every other major infectious disease in the history of mankind, prevention through vaccination can be the most cost-effective tool in eradicating disease burden. Existing TB treatment and control programs are essential to controlling the disease and minimizing its health impact, but innovative new tools like an effective vaccine will be necessary to get ahead of transmission and drive game-changing reductions in disease burden.

"Most people I speak to in the U.S. think they are already vaccinated against TB," notes Ms. Stoever, "but what they believe to be a vaccine is more than likely just the skin test commonly used to check whether a person has been infected with the TB bacteria." The existing TB vaccine – Bacille Calmette–Guerin, or BCG – protects children from some severe forms of TB, but it is unreliable in preventing infectious TB in adolescents and adults – the primary transmitters of the disease – and is not recommended for use in the United States. New, effective TB vaccines would provide the ultimate solution to the epidemic, transforming the effort against this disease by protecting vulnerable populations in the U.S. and around the world from TB's devastating impact.

Scientific progress in TB vaccine R&D is well underway, and investments of more than $600 million over the past decade have produced a robust portfolio of TB vaccine candidates, with more than a dozen candidates currently in clinical trials. Partnerships and collaborations are crucial to advancing the development of these candidates: no one organization or institution can do this alone. Governments, researchers and industry partners from around the world have contributed to the progress that has been made to date, but mobilizing additional partners and resources will be essential to sustaining progress in the field. Expanded contributions from new and existing partners like the U.S. government can help ensure that new TB vaccines are developed as quickly and efficiently as possible.

View the TB Crisis Tracker at www.aeras.org/tbtracker.

About Aeras
Aeras is a nonprofit biotech advancing the development of tuberculosis vaccines for the world. In collaboration with global partners in Africa, Asia, North America and Europe, Aeras is supporting the clinical testing of six experimental vaccines as well as a robust portfolio of earlier stage candidates. Aeras receives funding from Australian AID, the Bill & Melinda Gates Foundation, the UK Department for International Development, the Netherlands' Ministry of Foreign Affairs, and a range of other governments. Aeras is based in Rockville, Maryland; Cape Town, South Africa; and Beijing, China. www.aeras.org

SOURCE Aeras

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
DX World EXPO, LLC., a Lighthouse Point, Florida-based startup trade show producer and the creator of "DXWorldEXPO® - Digital Transformation Conference & Expo" has announced its executive management team. The team is headed by Levent Selamoglu, who has been named CEO. "Now is the time for a truly global DX event, to bring together the leading minds from the technology world in a conversation about Digital Transformation," he said in making the announcement.
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
"With Digital Experience Monitoring what used to be a simple visit to a web page has exploded into app on phones, data from social media feeds, competitive benchmarking - these are all components that are only available because of some type of digital asset," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
SYS-CON Events announced today that DXWorldExpo has been named “Global Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Digital Transformation is the key issue driving the global enterprise IT business. Digital Transformation is most prominent among Global 2000 enterprises and government institutions.
SYS-CON Events announced today that Datera, that offers a radically new data management architecture, has been named "Exhibitor" of SYS-CON's 21st International Cloud Expo ®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Datera is transforming the traditional datacenter model through modern cloud simplicity. The technology industry is at another major inflection point. The rise of mobile, the Internet of Things, data storage and Big...
"Outscale was founded in 2010, is based in France, is a strategic partner to Dassault Systémes and has done quite a bit of work with divisions of Dassault," explained Jackie Funk, Digital Marketing exec at Outscale, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We were founded in 2003 and the way we were founded was about good backup and good disaster recovery for our clients, and for the last 20 years we've been pretty consistent with that," noted Marc Malafronte, Territory Manager at StorageCraft, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Kubernetes is an open source system for automating deployment, scaling, and management of containerized applications. Kubernetes was originally built by Google, leveraging years of experience with managing container workloads, and is now a Cloud Native Compute Foundation (CNCF) project. Kubernetes has been widely adopted by the community, supported on all major public and private cloud providers, and is gaining rapid adoption in enterprises. However, Kubernetes may seem intimidating and complex ...
While the focus and objectives of IoT initiatives are many and diverse, they all share a few common attributes, and one of those is the network. Commonly, that network includes the Internet, over which there isn't any real control for performance and availability. Or is there? The current state of the art for Big Data analytics, as applied to network telemetry, offers new opportunities for improving and assuring operational integrity. In his session at @ThingsExpo, Jim Frey, Vice President of S...
"DivvyCloud as a company set out to help customers automate solutions to the most common cloud problems," noted Jeremy Snyder, VP of Business Development at DivvyCloud, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We focus on SAP workloads because they are among the most powerful but somewhat challenging workloads out there to take into public cloud," explained Swen Conrad, CEO of Ocean9, Inc., in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"As we've gone out into the public cloud we've seen that over time we may have lost a few things - we've lost control, we've given up cost to a certain extent, and then security, flexibility," explained Steve Conner, VP of Sales at Cloudistics,in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We provide IoT solutions. We provide the most compatible solutions for many applications. Our solutions are industry agnostic and also protocol agnostic," explained Richard Han, Head of Sales and Marketing and Engineering at Systena America, in this SYS-CON.tv interview at @ThingsExpo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"I think DevOps is now a rambunctious teenager – it’s starting to get a mind of its own, wanting to get its own things but it still needs some adult supervision," explained Thomas Hooker, VP of marketing at CollabNet, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.